Categories Health Care, U.S. Markets News

Intercept stock surges on positive data from liver fibrosis drug study

Intercept Pharmaceuticals (ICPT) had surged about 25% in the pre-market session on Tuesday after the biopharma company announced positive topline results from the phase 3 study for the treatment of patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH). Based on these results, Intercept intends to file for approval in the U.S. and Europe in the latter half of 2019.

Shares of Intercept traded down $0.38 on Friday and ended at $110.82. The stock, which hit a yearly high ($133.74) in early October, had surged about 25% in the pre-market trading today. The stock, which was expected to surpass its previous 52-week high today, didn’t carry the pre-market momentum and opened up 19% at $131.67.

“We are thrilled to report the first positive registrational Phase 3 study results in patients with NASH, a devastating disease that is on track to become a leading cause of liver transplant in coming years,” said CEO Mark Pruzanski.

Also read: Intercept Pharmaceuticals (ICPT) Q3 2018 earnings call transcript

The company plans to present the study results at the European Association for the Study of the Liver (EASL): The International Liver Congress 2019, which is scheduled to take place 10-14 April 2019 in Vienna, Austria.

It’s worth noting that biotech giant Gilead Sciences (GILD) reported its failure of late-stage study in patients with compensated cirrhosis due to NASH. The NASH market is projected to experience rapid growth in the future and many pharma companies are investing heavily in this area.

According to DelveInsight, the NASH market will experience significant annual growth over the 2016-2028 study period, as major-market sales increase up to $30.1 billion by 2028. The report also states that Intercept’s OCA is expected to grab maximum market share.

Intercept’s peers Viking Therapeutics (VKTX) and CymaBay Therapeutics (CBAY) also jumped today in pre-market hours, buoyed by the positive data from the New York-based pharma company.


We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips




Most Popular

DG Earnings Preview: What to look for when Dollar General reports Q3 results

Discount store chain Dollar General Corporation (NYSE: DG) will be reporting third-quarter results next week. Operating nearly 20,000 stores across the US, it is one of the largest supermarket chains

Dollar Tree (DLTR): A few points to note about the discount retailer’s Q3 performance

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) were up over 1% on Thursday. The stock has dropped 13% year-to-date. The discount retailer delivered third-quarter 2023 earnings results that did not

KR Earnings: Key quarterly highlights from Kroger’s Q3 2023 financial results

The Kroger Co. (NYSE: KR) reported its third quarter 2023 earnings results today. Total company sales were $34 billion compared to $34.2 billion for the same period last year. Identical sales


  1. Pingback: fue founder
  2. Pingback: fue
  3. Pingback: Course Load
  4. Pingback: Social Activities
  5. Pingback: faculty of dental
  6. Pingback: cage a squat
  7. Pingback: dalle caoutchouc
  8. Pingback: Fiverr Earn
  9. Pingback: Fiverr Earn
  10. Pingback: Fiverr Earn
  11. Pingback: Hooled strip led
  12. Pingback:
  13. Pingback:
  14. Pingback:
  15. Pingback: shipping broker
  16. Pingback: TLI
  17. Pingback:
  18. Pingback:
  19. Pingback: french bulldog
  20. Pingback: jute vs sisal rug
  21. Pingback: seo in Dubai
  22. Pingback: SEO in Kuwait
  23. Pingback: Local Piano Movers
  24. Pingback: bewerto
  25. Pingback: technology
  26. Pingback: future university
  27. Pingback: future university
  28. Pingback: french bulldog pin
  29. Pingback: multisbo slot
  30. Pingback: fue
  31. Pingback: Warranty
  32. Pingback: FUE
  33. Pingback: FUE
  34. Pingback: Classic Books 500
  35. Pingback: FiverrEarn
  36. Pingback: FiverrEarn
  37. Pingback: FiverrEarn
  38. Pingback: FiverrEarn
Add Comment
Viewing Highlight